Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 28, 2025 10:21 ET | Source: Research and Markets

Targeted Therapies for Non-Small Cell Lung Cancer (NSCLC): Addressing Ten Actionable Genomic Alterations in a Competitive Market

Dublin, April 28, 2025 (GLOBE NEWSWIRE) -- The "Current Trends in Targeted Therapies in Non-Small Cell Lung Cancer (NSCLC)" report has been added to ResearchAndMarkets.com's offering. This report...
April 08, 2022 13:00 ET | Source: Kura Oncology, Inc.

Kura Oncology Reports Preclinical Data Supporting Use of Tipifarnib to Prevent Emergence of Resistance to Osimertinib in Non-Small Cell Lung Cancer

– Late-breaking presentation at AACR demonstrates potential to significantly delay onset of drug resistance to EGFR-targeted therapies through combination with a farnesyl transferase inhibitor – –...
November 06, 2020 02:34 ET | Source: DelveInsight Business Research LLP

Correction: Non-Small Cell Lung Cancer Pipeline Expected to Offer Myriad of Novel Therapies in the Next Decade

Los Angeles, USA, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Non-Small Cell Lung Cancer Pipeline Expected to Offer Myriad of Novel Therapies in the Next Decade The Non-Small Cell Lung Cancer Pipeline...
November 02, 2020 10:17 ET | Source: DelveInsight Business Research LLP

Non-Small Cell Lung Cancer Pipeline Expected to Offer Myriad of Novel Therapies in the Next Decade

Los Angeles, USA, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Non-Small Cell Lung Cancer Pipeline Expected to Offer Myriad of Novel Therapies in the Next Decade The Non-Small Cell Lung Cancer Pipeline...
January 08, 2016 07:30 ET | Source: Transparency Market Research

Non-Small Cell Lung Cancer Therapeutics Market Expected to Reach US$ 15.1 Bn in 2023: Transparency Market Research

Albany, NY, Jan. 08, 2016 (GLOBE NEWSWIRE) -- Transparency Market Research has published a new market report titled, “Non Small Cell Lung Cancer Therapeutics Market - Global Industry Analysis,...